Essay
Published investment thesis on backing CEE biotech founders and the shift beyond pure software to science-backed companies with defensible IP.
Why We Invested in intoDNA
intoDNASMOK Ventures
JAN 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Why We Invested in intoDNA
SMOK Ventures 2025 Year-in-Review: Doubling Down on CEE Diaspora